Masetti, C., Lionetti, R., Lupo, M., Siciliano, M., Giannelli, V., Ponziani, F.r., et al. (2018). Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis. JOURNAL OF VIRAL HEPATITIS [10.1111/jvh.12982]. Dettagli
10.1111/jvh.12982
CitazioneMasetti, C., Lionetti, R., Lupo, M., Siciliano, M., Giannelli, V., Ponziani, F.r., et al. (2018). Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis. JOURNAL OF VIRAL HEPATITIS [10.1111/jvh.12982].Data2018-08-16idPUBBLICAZIONE_338620TipologiaArticolo su rivistaSSDSettore MED/17 - Malattie InfettiveTutti gli AutoriLack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosistipologiaMasetti, C; Lionetti, R; Lupo, M; Siciliano, M; Giannelli, V; Ponziani, Fr; Teti, E; Dell'Unto, C; Francioso, S; Brega, A; Montalbano, M; Visco-Comandini, U; Taibi, C; Galati, G; Vespasiani Gentilucci, U; Picardi, A; Andreoni, M; Pompili, M; Pellicelli, Am; D'Offizi, G; Gasbarrini, A; De Santis, A; Angelico, M